Cargando…
AAV-Mediated Combination Gene Therapy for Neuropathic Pain: GAD65, GDNF, and IL-10
Neuropathic pain is a chronic pain state characterized by nerve damage, inflammation, and nociceptive neuron hyperactivity. As the underlying pathophysiology is complex, a more effective therapy for neuropathic pain would be one that targets multiple elements. Here, we generated recombinant adeno-as...
Autores principales: | Kim, Daewook, Kim, Kyung-Ran, Kwon, Yejin, Kim, Minjung, Kim, Min-Ju, Sim, Yeomoon, Ji, Hyelin, Park, Jang-Joon, Cho, Jong-Ho, Choi, Heonsik, Kim, Sujeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378317/ https://www.ncbi.nlm.nih.gov/pubmed/32728596 http://dx.doi.org/10.1016/j.omtm.2020.06.018 |
Ejemplares similares
-
Enhanced susceptibility to stress and seizures in GAD65 deficient mice
por: Qi, Jin, et al.
Publicado: (2018) -
Induction of GDNF and GFRα-1 Following AAV1-Rheb(S16H) Administration in the Hippocampus in vivo
por: Yun, Dongyoung, et al.
Publicado: (2020) -
Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome
por: Gu Urban, Gucci Jijuan, et al.
Publicado: (2015) -
Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013) -
An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)